This medication is used to treat a certain type of cancer (acute lymphocytic leukemia-ALL). Acute lymphocytic leukemia is a cancer of the blood in which a particular kind of white blood cell is growing out of control. Blinatumomab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. Before you receive this medication, you may be given a corticosteroid medicine to help reduce infusion reactions. This medication comes in an injectable form to be given directly into the vein by continuous IV infusion for 4 weeks (28 days), followed by a 2 week break.
BEXAROTENE is a Schedule H drug.
AZACITIDINE is an Over-the-counter (OTC) drug.
Altretamine is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.. It is used to ease the symptoms of ovarian cancer. This medication will not treat the cancer itself. Altretamine is usually given after other cancer medicines have been tried without success. Altretamine belongs to a group of drugs called alkylating agents. Common side effects of altretamine include loss of appetite, nausea, vomiting, and weakness.
ALDESLEUKIN is a Schedule H drug.
ABIRATERONE ACETATE is a Schedule H drug.
PROCARBAZINE is a Schedule H drug.
MITOTANE is a Schedule H drug.
IRINOTECAN is a Schedule H drug.
HEXAMINOLEVULINATE is a Schedule H drug.